Baum C - Search Results

1

Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection.

Baum C, Eckert HG, Stockschläder M, Just U, Hegewisch-Becker S, Hildinger M, Uhde A, John J, Ostertag W. Baum C, et al. J Hematother. 1996 Aug;5(4):323-9. doi: 10.1089/scd.1.1996.5.323. J Hematother. 1996. PMID: 8877707 Review.

2

Genetic protection of repopulating hematopoietic cells with an improved MDR1-retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice.

Carpinteiro A, Peinert S, Ostertag W, Zander AR, Hossfeld DK, Kühlcke K, Eckert HG, Baum C, Hegewisch-Becker S. Carpinteiro A, et al. Among authors: baum c. Int J Cancer. 2002 Apr 10;98(5):785-92. doi: 10.1002/ijc.10206. Int J Cancer. 2002. PMID: 11920652

3

Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.

Baum C, Hegewisch-Becker S, Eckert HG, Stocking C, Ostertag W. Baum C, et al. J Virol. 1995 Dec;69(12):7541-7. doi: 10.1128/JVI.69.12.7541-7547.1995. J Virol. 1995. PMID: 7494260 Free PMC article.

4

Activity of Friend mink cell focus-forming retrovirus during myelo-erythroid hematopoiesis.

Baum C, Eckert HG, Stocking C, Ostertag W. Baum C, et al. Exp Hematol. 1996 Feb;24(2):364-70. Exp Hematol. 1996. PMID: 8641367

5

High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors.

Eckert HG, Stockschläder M, Just U, Hegewisch-Becker S, Grez M, Uhde A, Zander A, Ostertag W, Baum C. Eckert HG, et al. Among authors: baum c. Blood. 1996 Nov 1;88(9):3407-15. Blood. 1996. PMID: 8896405 Free article.

6

Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors.

Hildinger M, Fehse B, Hegewisch-Becker S, John J, Rafferty JR, Ostertag W, Baum C. Hildinger M, et al. Among authors: baum c. Hum Gene Ther. 1998 Jan 1;9(1):33-42. doi: 10.1089/hum.1998.9.1-33. Hum Gene Ther. 1998. PMID: 9458240

7

FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells.

Hildinger M, Eckert HG, Schilz AJ, John J, Ostertag W, Baum C. Hildinger M, et al. Among authors: baum c. Gene Ther. 1998 Nov;5(11):1575-9. doi: 10.1038/sj.gt.3300759. Gene Ther. 1998. PMID: 9930313

8

Design of 5' untranslated sequences in retroviral vectors developed for medical use.

Hildinger M, Abel KL, Ostertag W, Baum C. Hildinger M, et al. Among authors: baum c. J Virol. 1999 May;73(5):4083-9. doi: 10.1128/JVI.73.5.4083-4089.1999. J Virol. 1999. PMID: 10196304 Free PMC article.

9

Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking.

Hildinger M, Schilz A, Eckert HG, Bohn W, Fehse B, Zander A, Ostertag W, Baum C. Hildinger M, et al. Among authors: baum c. Gene Ther. 1999 Jul;6(7):1222-30. doi: 10.1038/sj.gt.3300942. Gene Ther. 1999. PMID: 10455430

10

Retroviral vector-mediated gene expression in hematopoietic cells.

Baum C, Richters A, Ostertag W. Baum C, et al. Curr Opin Mol Ther. 1999 Oct;1(5):605-12. Curr Opin Mol Ther. 1999. PMID: 11249667 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

857 results

Search Page

Filters